Affymetrix Inc. of Santa Clara, Calif.,
and Partners HealthCare of Boston, Mass., have entered into a three-year translational
research collaboration to develop microarray-based diagnostics for complex diseases
such as newborn hearing loss, autism and hypertrophic cardiomyopathy. As part of
the agreement, researchers from the Boston company will use Affymetrix’s genotyping,
resequencing and expression technologies in their labs, allowing them to develop
validated diagnostic tests.
MORE FROM PHOTONICS MEDIA